Phase 1b Interim Results: Venetoclax (ABT-199/GDC-0199) in Combination with Bortezomib (BTZ) and Dexamethasone (Dex) in Relapsed/Refractory (R/R) Multiple Myeloma (MM)

Autor: Touzeau, C., Chanan-Khan, A., Roberts, A.W., Agarwal, A., Facon, T., Lebovic, D., Moreau, P., Darden, D., Morris, L., Ross, J., Salem, A., Munasinghe, W., Zhu, M., Leverson, J., Enschede, S., Humerickhouse, R., Harrison, S.J.
Zdroj: In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e272-e273
Databáze: ScienceDirect
Externí odkaz: